These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6747601)
1. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice. Schnurr DP; Cao Y; Schmidt NJ J Gen Virol; 1984 Jul; 65 ( Pt 7)():1197-201. PubMed ID: 6747601 [TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice. Schnurr DP; Schmidt NJ Med Microbiol Immunol; 1984; 173(1):1-7. PubMed ID: 6088960 [TBL] [Abstract][Full Text] [Related]
3. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions. Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602 [TBL] [Abstract][Full Text] [Related]
4. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease. Hashimoto I; Tatsumi M; Nakagawa M Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043 [TBL] [Abstract][Full Text] [Related]
5. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice. Kishimoto C; Hiraoka Y; Takada H Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990 [TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix remodeling in coxsackievirus B3 myocarditis. Kishimoto C; Kitazawa M; Hiraoka Y; Takada H Clin Immunol Immunopathol; 1997 Oct; 85(1):47-55. PubMed ID: 9325069 [TBL] [Abstract][Full Text] [Related]
7. Myocardial changes after infection with Coxsackie virus B3 in nude mice. Hashimoto I; Komatsu T Br J Exp Pathol; 1978 Feb; 59(1):13-20. PubMed ID: 638027 [TBL] [Abstract][Full Text] [Related]
8. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Kishimoto C; Abelmann WH Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791 [TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells. Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939 [TBL] [Abstract][Full Text] [Related]
10. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051 [TBL] [Abstract][Full Text] [Related]
11. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis. Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072 [TBL] [Abstract][Full Text] [Related]
12. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction. Okada I; Matsumori A; Kyu B Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265 [TBL] [Abstract][Full Text] [Related]
13. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis. Khatib R; Reyes MP; Khatib G; Giraldo A Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064 [TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice. Leipner C; Borchers M; Merkle I; Stelzner A J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212 [TBL] [Abstract][Full Text] [Related]